Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Czerniecki

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Expert Review of Clinical Pharmacology|November 25, 2011
Developing dendritic cell-based therapies to condition immune responses to novel oncogenic proteins and stem cellsAnupama Sharma, Brian J Czerniecki
Pathology Research International|January 22, 2011
Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progressionHolly Graves, Brian J Czerniecki
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Combining innate immunity with radiation therapy for cancer treatmentGary K Koski, Brian J Czerniecki
Current Treatment Options in Oncology|May 5, 2005
Dendritic cells in melanoma immunotherapyMark B Faries, Brian J Czerniecki
PET Clinics|May 10, 2016
Diagnosis of MelanomaGiorgos C Karakousis, Brian J Czerniecki
Oncoimmunology|October 25, 2019
CD4<sup>+</sup> Th1 to the rescue in HER-2+ breast cancerLea Lowenfeld, Shuwen Xu, Brian J Czerniecki
NPJ Breast Cancer|March 21, 2020
Clinical development of immunotherapies for HER2<sup>+</sup> breast cancer: a review of HER2-directed monoclonal antibodies and beyondRicardo L B Costa, Brian J Czerniecki
Oncoimmunology|August 8, 2014
Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cellsErik Berk, Shuwen Xu, Brian J Czerniecki
Cancer Journal (Sudbury, Mass.)|January 23, 2015
Sentinel lymph node biopsy in breast cancer: a work in progressAbhishek Chatterjee, Nicholas Serniak, Brian J Czerniecki
Vaccines|September 8, 2015
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer TherapyJulia Terhune, Erik Berk, Brian J Czerniecki
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Expert Review of Clinical Pharmacology|November 25, 2011
Developing dendritic cell-based therapies to condition immune responses to novel oncogenic proteins and stem cellsAnupama Sharma, Brian J Czerniecki
Pathology Research International|January 22, 2011
Circulating tumor cells in breast cancer patients: an evolving role in patient prognosis and disease progressionHolly Graves, Brian J Czerniecki
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Combining innate immunity with radiation therapy for cancer treatmentGary K Koski, Brian J Czerniecki
Current Treatment Options in Oncology|May 5, 2005
Dendritic cells in melanoma immunotherapyMark B Faries, Brian J Czerniecki
PET Clinics|May 10, 2016
Diagnosis of MelanomaGiorgos C Karakousis, Brian J Czerniecki
Oncoimmunology|October 25, 2019
CD4<sup>+</sup> Th1 to the rescue in HER-2+ breast cancerLea Lowenfeld, Shuwen Xu, Brian J Czerniecki
NPJ Breast Cancer|March 21, 2020
Clinical development of immunotherapies for HER2<sup>+</sup> breast cancer: a review of HER2-directed monoclonal antibodies and beyondRicardo L B Costa, Brian J Czerniecki
Oncoimmunology|August 8, 2014
Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cellsErik Berk, Shuwen Xu, Brian J Czerniecki
Cancer Journal (Sudbury, Mass.)|January 23, 2015
Sentinel lymph node biopsy in breast cancer: a work in progressAbhishek Chatterjee, Nicholas Serniak, Brian J Czerniecki
Vaccines|September 8, 2015
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer TherapyJulia Terhune, Erik Berk, Brian J Czerniecki
Pageof 16